Cargando…

Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant

Detalles Bibliográficos
Autores principales:	Issaragrisil, S, Cheng-Hwai, T, Bunworasate, U, Su-Peng, Y, Hung, L Y, Tee, G Y, Wahid, S F A, Chin, N S, Puavilai, T, Gin, G G, Piu, K L, Wen-Li, H, Tsai-Yun, C, Numbenjapon, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292601/ https://www.ncbi.nlm.nih.gov/pubmed/27841857 http://dx.doi.org/10.1038/bmt.2016.245

Ejemplares similares

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013)

Salvage HLA-haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide for graft failure in non-malignant disorders
por: Albert, Michael H., et al.
Publicado: (2021)

PB2195: MOBILIZATION WITH CYTARABINE AND GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) GIVES BETTER YIELD THAN MOBILIZATION WITH G-CSF ALONE OR COMBINED WITH CYCLOPHOSPHAMIDE
por: Simeonov, S., et al.
Publicado: (2022)

G‐CSF Indirectly Induces Apoptosis of Osteoblasts During Hematopoietic Stem Cell Mobilization
por: Li, S‐D, et al.
Publicado: (2017)

P932: ON-DEMAND PLERIXAFOR WITH CYCLOPHOSPHAMIDE AND G-CSF FOR HEMATOPOIETIC STEM-CELL MOBILIZATION IN MULTIPLE MYELOMA PATIENTS: FINAL RESULTS OF THE MOZOBL06877 STUDY
por: Mina, R., et al.
Publicado: (2022)

Post Transplantation Cyclophosphamide Improves Outcome of Autologous Hematopoietic Stem Cell Transplantation in Animal Model of Multiple Sclerosis
por: Kasarełło, Kaja, et al.
Publicado: (2021)

The possible cost effectiveness of peripheral blood stem cell mobilization with cyclophosphamide and the late addition of G-CSF.
por: Min, Y. J., et al.
Publicado: (2000)

Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children
por: Meraz, José Eugenio Vázquez, et al.
Publicado: (2016)

Corrigendum to “Stem Cell Mobilization with G-CSF versus Cyclophosphamide plus G-CSF in Mexican Children”
por: Vázquez Meraz, José Eugenio, et al.
Publicado: (2016)

Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy?
por: Patel, H, et al.
Publicado: (2009)

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
por: Crees, Zachary D., et al.
Publicado: (2023)

Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation
por: Schmitt, Michael, et al.
Publicado: (2014)

Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma
por: Delphine, Lebon, et al.
Publicado: (2023)

P1303: DARATUMUMAB-BASED MAINTENANCE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AFTER SALVAGE AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Pasvolsky, Oren, et al.
Publicado: (2023)

CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
por: Lundblad, Katarina, et al.
Publicado: (2023)

Intraoperative cell salvage with autologous transfusion in liver transplantation
por: Pinto, Marcelo A, et al.
Publicado: (2019)

Bortezomib-thalidomide-dexamethasone-cisplatin-doxorubicin-cyclophosphamide-etoposide as a Salvage and Bridging Regimen before Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Multiple Myeloma
por: Togano, Tomiteru, et al.
Publicado: (2022)

Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia
por: Shi, Yuan-Yuan, et al.
Publicado: (2023)

G‐CSF/GM‐CSF‐induced hematopoietic dysregulation in the progression of solid tumors
por: He, Kai, et al.
Publicado: (2022)

Salvage of Failed Prosthetic Breast Reconstructions by Autologous Conversion With Free Tissue Transfers
por: Rabey, N. G., et al.
Publicado: (2013)

Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes
por: Muñoz, Juan Pablo, et al.
Publicado: (2023)

Sarcodon imbricatus polysaccharides improve mouse hematopoietic function after cyclophosphamide-induced damage via G-CSF mediated JAK2/STAT3 pathway
por: Wang, Xue, et al.
Publicado: (2018)

Calf Spleen Extractive Injection protects mice against cyclophosphamide-induced hematopoietic injury through G-CSF-mediated JAK2/STAT3 signaling
por: Lu, Wenqian, et al.
Publicado: (2017)

Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
por: Fante, Matthias A., et al.
Publicado: (2020)

PB2199: A REAL WORLD STUDY OF PEG-RHG-CSF ON HEMATOPOIETIC RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Xu, J., et al.
Publicado: (2022)

Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma
por: Skerget, Matevz, et al.
Publicado: (2016)

Effect of alternating combination chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, cisplatin, and etoposide for small cell lung cancer on hematopoietic progenitors in the peripheral blood.
por: Shimizu, E., et al.
Publicado: (1993)

Post-Transplant Cyclophosphamide and Thymoglobulin, a Graft-Versus-Host Disease Prophylaxis in Matched Sibling Donor Peripheral Blood Stem Cell Transplantations
por: Kunacheewa, Chutima, et al.
Publicado: (2020)

Hematopoietic stem cell mobilization for autologous transplantation in multiple myeloma patients previously exposed to cyclophosphamide, thalidomide, and dexamethasone: is granulocyte-colony stimulating factor alone enough?()
por: Vigorito, Afonso Celso
Publicado: (2016)

Skull Base Csf- Leak Closure with Autologous Fibrin Sealant
por: Poma, Salvatore, et al.
Publicado: (2021)

Clinicopathological examination of ESD as salvage therapy for esophageal cancer after definitive chemo-radiation therapy
por: Kagawa, Tomo, et al.
Publicado: (2018)

Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer
por: Su, Meng, et al.
Publicado: (2019)

Salvage surgery following immuno-chemo-radiotherapy for advanced non-small cell lung cancer
por: Nawashiro, Ayako, et al.
Publicado: (2022)

Results of emergency salvage lung resection after chemo- and/or radiotherapy among patients with lung cancer
por: Hino, Haruaki, et al.
Publicado: (2022)

Haploidentical Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide for Sézary Syndrome
por: Kanda-Kato, Madoka, et al.
Publicado: (2020)

Pharmacometabonomic association of cyclophosphamide 4‐hydroxylation in hematopoietic cell transplant recipients
por: McCune, Jeannine S., et al.
Publicado: (2022)

Hematopoietic Effects of Angelica gigas Nakai Extract on Cyclophosphamide-Induced Myelosuppression
por: Kang, Mincheol, et al.
Publicado: (2022)

SHIPi Enhances Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Fernandes, Sandra, et al.
Publicado: (2015)

Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
por: Yarlagadda, Lakshmi, et al.
Publicado: (2021)

Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF versus G-CSF alone
por: Sung, Anthony D., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vjamala8gmt1hc9d1ir9l0prsv